Remarkably, the functional cooperation of GPS2 with NCOR and its antagonism of PPARα is further supported by the correlation analysis of human NAFLD/NASH liver transcriptomes, suggesting conservation of the GPS2–NCOR partnership in driving NAFLD in mice and humans. Here, GPS2 is linked to metabolic dysfunction-associated steatotic liver disease.